UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

Annals of oncology, 2012-10, Vol.23 Suppl 7, p.vii155-vii166

2012

Volltextzugriff (PDF)

Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: Correlation with pathological outcome

Gynecologic oncology, 2013-02, Vol.128 (2), p.233-238

2013

Volltextzugriff (PDF)

Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects

Annals of oncology, 2006-02, Vol.17 (2), p.232-238

2006

Volltextzugriff (PDF)

Relative prevalence of high risk HPV genotypes in a US population: Insights before rollout of the next generation 9-valent HPV vaccine

Gynecologic oncology, 2015-04, Vol.137, p.16-16

2015

Volltextzugriff (PDF)

Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in Active Surveillance (AS) patients with recurrent Non-Muscle Invasive Bladder Cancer (NMIBC): Results from the Bladder Cancer Italian Active Surveillance (BIAS) project

European urology open science (Online), 2020-07, Vol.19, p.e1010

2020

Volltextzugriff (PDF)

P191 Macrocytosis predicts response to metronomic chemotherapy with capecitabine and cyclophosphamide in combination with bevacizumab

Breast (Edinburgh), 2011, Vol.20, p.S41-S42

2011

Volltextzugriff (PDF)

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications

Annals of oncology, 2008-05, Vol.19 (5), p.891-897

2008

Volltextzugriff (PDF)

Thyroid hormones reference ranges check from local population database

Clinica chimica acta, 2019-06, Vol.493, p.S332-S333

2019

Volltextzugriff (PDF)

1838P Do irinotecan (IRI) dose reductions driven by UGT1A128 genotyping prevent IRI-related severe neutropenia? A real-world study

Annals of oncology, 2020-09, Vol.31, p.S1056-S1056

2020

Volltextzugriff (PDF)

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

Annals of oncology, 2002, Vol.13 (1), p.73-80

2002

Volltextzugriff (PDF)

Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy

Annals of oncology, 2002-05, Vol.13 (5), p.710-715

2002

Volltextzugriff (PDF)

Prognostic role of CA15.3 in 7942 patients with operable breast cancer

Breast cancer research and treatment, 2012-02, Vol.132 (1), p.317-326

2012

Volltextzugriff (PDF)

1324 Detection of circulating tumour cells in locally advanced colorectal cancer: preliminary data

European journal of cancer supplements, 2009, Vol.7 (2), p.146-146

2009

Volltextzugriff (PDF)

P10 Detection of circulating tumor cells (CTCs) in Stage cT3–4orN+ rectal cancer patients (pts) undergoing combined neoadjuvant therapy plus curative surgery. Preliminary data

European journal of cancer supplements, 2009, Vol.7 (4), p.35-35

2009

Volltextzugriff (PDF)

Humanitas COVID-19 Task Force Venous and Arterial Thromboembolic Complications in COVID-19 Patients Admitted to an Academic Hospital in Milan, Italy

Journal of vascular surgery. Venous and lymphatic disorders (New York, NY), 2020-11, Vol.8 (6), p.1119-1119

2020

Volltextzugriff (PDF)

Circulating endothelial cell levels in psoriatic patients and their modification after an anti-TNF-alpha (Etanercept) treatment

Journal of the European Academy of Dermatology and Venereology, 2014-05, Vol.28 (5), p.590-596

2014

Volltextzugriff (PDF)

41P Circulating Tumor Cells (CTCs) and Metronomic Oral Vinorelbine (OV) in Advanced Breast Cancer (ABC) Patients (PTS): Exploratory Prospective Analysis

Annals of oncology, 2012-05, Vol.23, p.ii26

2012

Volltextzugriff (PDF)

Effect of tamoxifen at low doses on ultrasensitive C‐reactive protein in healthy women

Journal of thrombosis and haemostasis, 2003-10, Vol.1 (10), p.2149-2152

2003

Volltextzugriff (PDF)

Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phase

Annals of oncology, 2003-10, Vol.14 (10), p.1477-1483

2003

Volltextzugriff (PDF)

INFLUENZA DELLA ANTIBIOTICOTERAPIA SUL DIFFERENTIAL TIME TO POSITIVITY (DTP) NELLE BATTERIEMIE CVC-CORRELATE

Microbiologia Medica, 2007-09, Vol.22 (3)

2007

Volltextzugriff (PDF)

701 IMMUNOMAGNETIC QUANTIFICATION OF CIRCULATING TUMOUR CELLS (CTCS) AS NEW PROGNOSTIC AND PREDICTIVE FACTOR IN CASTRATION RESISTANT PROSTATE CANCER (CRPC): PRELIMINARY RESULTS

European urology supplements : official journal of the European Association of Urology, 2009-03, Vol.8 (4), p.296-296

2009

Volltextzugriff (PDF)

385 A phase II trial to assess the efficacy and safety of gefitinib (Iressa™) in patients with metastatic hormone refractory prostate cancer (HRPC) who progressed on treatment with a luteinising hormone releasing hormone analogue (or post orchiectomy) plus an antiandrogen

European journal of cancer supplements, 2004-09, Vol.2 (8), p.115-116

2004

Volltextzugriff (PDF)

Low-dose tamoxifen trial in healthy women

European journal of cancer (1990), 1997-09, Vol.33, p.S10-S11

1997

Volltextzugriff (PDF)

Prognostic value of troponin i in cardiac risk stratification of cancer patients undergoing high-dose chemotherap

ACC current journal review, 2004-09, Vol.13 (9), p.12-13

2004

Volltextzugriff (PDF)

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

ACC current journal review, 2001, Vol.10 (1), p.55-55

2001

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: Correlation with pathological outcome

Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects

Relative prevalence of high risk HPV genotypes in a US population: Insights before rollout of the next generation 9-valent HPV vaccine

Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in Active Surveillance (AS) patients with recurrent Non-Muscle Invasive Bladder Cancer (NMIBC): Results from the Bladder Cancer Italian Active Surveillance (BIAS) project

P191 Macrocytosis predicts response to metronomic chemotherapy with capecitabine and cyclophosphamide in combination with bevacizumab

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications

Thyroid hormones reference ranges check from local population database

1838P Do irinotecan (IRI) dose reductions driven by UGT1A128 genotyping prevent IRI-related severe neutropenia? A real-world study

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy

Prognostic role of CA15.3 in 7942 patients with operable breast cancer

1324 Detection of circulating tumour cells in locally advanced colorectal cancer: preliminary data

P10 Detection of circulating tumor cells (CTCs) in Stage cT3–4orN+ rectal cancer patients (pts) undergoing combined neoadjuvant therapy plus curative surgery. Preliminary data

Humanitas COVID-19 Task Force Venous and Arterial Thromboembolic Complications in COVID-19 Patients Admitted to an Academic Hospital in Milan, Italy

Circulating endothelial cell levels in psoriatic patients and their modification after an anti-TNF-alpha (Etanercept) treatment

41P Circulating Tumor Cells (CTCs) and Metronomic Oral Vinorelbine (OV) in Advanced Breast Cancer (ABC) Patients (PTS): Exploratory Prospective Analysis

Effect of tamoxifen at low doses on ultrasensitive C‐reactive protein in healthy women

Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phase

INFLUENZA DELLA ANTIBIOTICOTERAPIA SUL DIFFERENTIAL TIME TO POSITIVITY (DTP) NELLE BATTERIEMIE CVC-CORRELATE

701 IMMUNOMAGNETIC QUANTIFICATION OF CIRCULATING TUMOUR CELLS (CTCS) AS NEW PROGNOSTIC AND PREDICTIVE FACTOR IN CASTRATION RESISTANT PROSTATE CANCER (CRPC): PRELIMINARY RESULTS

385 A phase II trial to assess the efficacy and safety of gefitinib (Iressa™) in patients with metastatic hormone refractory prostate cancer (HRPC) who progressed on treatment with a luteinising hormone releasing hormone analogue (or post orchiectomy) plus an antiandrogen

Low-dose tamoxifen trial in healthy women

Prognostic value of troponin i in cardiac risk stratification of cancer patients undergoing high-dose chemotherap

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

Suchergebnisse filtern